| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
3 companies
Parker Geoffrey M. is a Chief Financial Officer at ALLO with holdings across 3 companies. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $3.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2018 | PRGO Perrigo Co Plc | Director | Buy | 3,000 | $65.35 | $196,058.10 | +120.0% | |
| Dec 9, 2016 | VIRX Viracta Therapeutics, Inc. | Director | Buy | 3,740 | $3.87 | $14,476.96 | +2.9% | |
| Nov 21, 2016 | PRGO Perrigo Co Plc | Director | Buy | 2,500 | $88.75 | $221,875.00 | New | |
| May 26, 2016 | VIRX Viracta Therapeutics, Inc. | Director | Buy | 9,500 | $0.47 | $4,454.55 | +18.1% | |
| May 25, 2016 | VIRX Viracta Therapeutics, Inc. | Director | Buy | 52,505 | $0.47 | $24,813.93 | +175.0% |